CaƱendo, Lourdes Y.
HRN: 26-38-18 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/14/2024
SILVER SULFADIAZINE 1%, 25G CREAM (TUBE)
12/14/2024
12/21/2024
TOPICAL
1%
BID
Infected Wound
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes